Pridopidine in Amyotrophic Lateral Sclerosis
This randomized platform trial investigates whether pridopidine, a sigma-1 receptor agonist, impacted disease progression among patients with amyotrophic lateral sclerosis.
This randomized platform trial investigates whether pridopidine, a sigma-1 receptor agonist, impacted disease progression among patients with amyotrophic lateral sclerosis.
